CHU Saint Etienne Hôpital Nord

Saint-Priest-en-Jarez 42055

0 studies enrolling now · 2 studies all time

What they study most

FSGS, Glomerulonephritis, Membranous, antiPLA2R Positive

Studies at this site

• A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB — Recruiting now
• Trial to Assess Safety and Efficacy of MOR202 in Anti-PLA2R + Membranous Nephropathy (aMN) — Completed